New Advances in Alzheimer’s Treatments (virtual)

On Wednesday, June 28, 6pm, learn about the new treatment approved by the FDA, who may benefit, and steps for access. This special program created by the Alzheimer’s Association is designed for people considering options for future treatment, and was introduced with the FDA approval of aducanumab in summer 2021. Presented by the Alzheimer’s Association, Greater New Jersey Chapter. Please visit www.mcl.org to register to receive the link to program.